Published March 19, 2016 | Version v1
Journal article Open

Antiarrhythmic effect of growth factor-supplemented cardiac progenitor cells in chronic infarcted heart

  • 1. Department of Life Sciences, University of Parma, Italy;
  • 2. Department of Biomedical, Biotechnological and Translational Sciences, University of Parma, Italy;
  • 3. Department of Biomedical, Biotechnological and Translational Sciences, University of Parma, Italy;; Cardiac Stem Cell Interdepartmental Center "CISTAC," University of Parma, Italy
  • 4. Humanitas Clinical and Research Center, Rozzano (MI), Italy;
  • 5. Humanitas Clinical and Research Center, Rozzano (MI), Italy;; Institute of Genetic and Biomedical Research–UOS Milan–National Research Council, Milan, Italy;
  • 6. Department of Experimental Medicine, Section of Pharmacology, Second University of Naples, Italy;
  • 7. Department of Life Sciences, University of Parma, Italy;; Cardiac Stem Cell Interdepartmental Center "CISTAC," University of Parma, Italy
  • 8. Department of Clinical and Experimental Medicine, University of Parma, Italy;; Cardiac Stem Cell Interdepartmental Center "CISTAC," University of Parma, Italy

Description

c-Kitpos cardiac progenitor cells (CPCs) represent a successful approach in healing the infarcted heart and rescuing its mechanical function, but electrophysiological consequences are uncertain. CPC mobilization promoted by hepatocyte growth factor (HGF) and IGF-1 improved electrogenesis in myocardial infarction (MI). We hypothesized that locally delivered CPCs supplemented with HGF + IGF-1 (GFs) can concur in ameliorating electrical stability of the regenerated heart. Adult male Wistar rats (139 rats) with 4-wk-old MI or sham conditions were randomized to receive intramyocardial injection of GFs, CPCs, CPCs + GFs, or vehicle (V). Enhanced green fluorescent protein-tagged CPCs were used for cell tracking. Vulnerability to stress-induced arrhythmia was assessed by telemetry-ECG. Basic cardiac electrophysiological properties were examined by epicardial multiple-lead recording. Hemodynamic function was measured invasively. Hearts were subjected to anatomical, morphometric, immunohistochemical, and molecular biology analyses. Compared with V and at variance with individual CPCs, CPCs + GFs approximately halved arrhythmias in all animals, restoring cardiac anisotropy toward sham values. GFs alone reduced arrhythmias by less than CPCs + GFs, prolonging ventricular refractoriness without affecting conduction velocity. Concomitantly, CPCs + GFs reactivated the expression levels of Connexin-43 and Connexin-40 as well as channel proteins of key depolarizing and repolarizing ion currents differently than sole GFs. Mechanical function and anatomical remodeling were equally improved by all regenerative treatments, thus exhibiting a divergent behavior relative to electrical aspects. Conclusively, we provided evidence of distinctive antiarrhythmic action of locally injected GF-supplemented CPCs, likely attributable to retrieval of Connexin-43, Connexin-40, and Cav1.2 expression, favoring intercellular coupling and spread of excitation in mended heart.

Files

fulltext.pdf

Files (10.5 MB)

Name Size Download all
md5:c3b3cb4a37787bd1f3d5a2365504106c
10.5 MB Preview Download